Spots Global Cancer Trial Database for Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.
Official Title: A Randomised, Double-Blind, Parallel-group, Multicentre, Phase III Study Comparing the Efficacy and Tolerability of Fulvestrant (FASLODEX™) 500 mg With Fulvestrant (FASLODEX™) 250 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy
Study ID: NCT00099437
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to evaluate the efficacy of a new dose of 500 mg Fulvestrant with the standard dose of 250 mg in postmenopausal women with oestrogen receptor positive advanced breast cancer who have failed on a previous endocrine treatment.
Detailed Description:
Eligibility
Minimum Age: 45 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Research Site, Casa Grande, Arizona, United States
Research Site, Fountain Valley, California, United States
Research Site, New Britain, Connecticut, United States
Research Site, Crystal River, Florida, United States
Research Site, Fort Lauderdale, Florida, United States
Research Site, Urbana, Illinois, United States
Research Site, Rosedale, Maryland, United States
Research Site, Detroit, Michigan, United States
Research Site, Kansas City, Missouri, United States
Research Site, Saint Louis, Missouri, United States
Research Site, Voorhees, New Jersey, United States
Research Site, Greenville, North Carolina, United States
Research Site, Pasadena, Texas, United States
Research Site, West Bend, Wisconsin, United States
Research Site, Brasschaat, , Belgium
Research Site, Brussels, , Belgium
Research Site, Brussels, , Belgium
Research Site, Edegem, , Belgium
Research Site, Gent, , Belgium
Research Site, Hasselt, , Belgium
Research Site, Liège, , Belgium
Research Site, Turnhout, , Belgium
Research Site, Barretos, , Brazil
Research Site, Londrina, , Brazil
Research Site, Porto Alegre, , Brazil
Research Site, Recife, , Brazil
Research Site, Salvador, , Brazil
Research Site, Sao Paulo, , Brazil
Research Site, Antofagasta, , Chile
Research Site, Santiago, , Chile
Research Site, Santiago, , Chile
Research Site, Bogota, , Colombia
Research Site, Cali, , Colombia
Research Site, Brno, , Czechia
Research Site, Ceske Budejovice, , Czechia
Research Site, Pardubice, , Czechia
Research Site, Praha 10, , Czechia
Research Site, Praha 2, , Czechia
Research Site, Praha 8, , Czechia
Research Site, Tabor, , Czechia
Research Site, Nyíregyháza, , Hungary
Research Site, Szombathely, , Hungary
Research Site, Székesfehérvár, , Hungary
Research Site, Ansari Nagar, , India
Research Site, Bhopal, , India
Research Site, Hyderabad, , India
Research Site, Jaipur, , India
Research Site, Kolkata, , India
Research Site, Manipal, , India
Research Site, Marg Jaipur, , India
Research Site, Mumbai, , India
Research Site, Pune, , India
Research Site, Trivandrum, , India
Research Site, Vellore, , India
Research Site, Aviano, , Italy
Research Site, Bergamo, , Italy
Research Site, Carpi, , Italy
Research Site, Genova, , Italy
Research Site, Prato, , Italy
Research Site, Reggio Emilia, , Italy
Research Site, Varese, , Italy
Research Site, Floriana, , Malta
Research Site, Mexico City, , Mexico
Research Site, Mexico, , Mexico
Research Site, Mexico, , Mexico
Research Site, Białystok, , Poland
Research Site, Poznań, , Poland
Research Site, Łódź, , Poland
Research Site, Ivanovo, , Russian Federation
Research Site, Kazan, Tatarstan, , Russian Federation
Research Site, Kazan, Tatarstan, , Russian Federation
Research Site, Krasnodar, , Russian Federation
Research Site, Lipetsk, , Russian Federation
Research Site, Moscow, , Russian Federation
Research Site, Moscow, , Russian Federation
Research Site, Moscow, , Russian Federation
Research Site, Moscow, , Russian Federation
Research Site, Nizhniy Novgorod, , Russian Federation
Research Site, Obninsk, , Russian Federation
Research Site, Ryazan, , Russian Federation
Research Site, St-Petersburg, , Russian Federation
Research Site, St.-Petersburg, , Russian Federation
Research Site, St.Petersburg, , Russian Federation
Research Site, Yaroslavl, , Russian Federation
Research Site, Bardejov, , Slovakia
Research Site, Bratislava, , Slovakia
Research Site, Nitra, , Slovakia
Research Site, Trnava, , Slovakia
Research Site, A Coruña, , Spain
Research Site, Madrid, , Spain
Research Site, Malaga, , Spain
Research Site, Oviedo, , Spain
Research Site, Salamanca, , Spain
Research Site, Sevilla, , Spain
Research Site, Cherkasy, , Ukraine
Research Site, Dnipro, , Ukraine
Research Site, Donetsk, , Ukraine
Research Site, Kyiv, , Ukraine
Research Site, Lviv, , Ukraine
Research Site, Sumy, , Ukraine
Research Site, Ternopil, , Ukraine
Research Site, Uzhhorod, , Ukraine
Research Site, Caracas, , Venezuela
Contact Details
Name: Faslodex Medical Science Director, MD
Affiliation: AstraZeneca
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
